Telaprevir

Contraindicated

Telaprevir Colchicine Colcrys Explained Increased colchicine exposure and an increased risk of colchicine toxicity Details Telaprevir Simvastatin Flolipid Explained Increased simvastatin concentrations Details Telaprevir Alfuzosin UroXatral Increased alfuzosin concentrations Details Telaprevir Dihydroergotamine Injection DHE-45® Injection Increased dihydroergotamine exposure and an increased risk of dihydroergotamine-related adverse effects Details Telaprevir Dihydroergotamine Nasal Spray Migranal Increased dihydroergotamine exposure and an increased risk of dihydroergotamine-related adverse effects Details Telaprevir Finerenone Kerendia Increased finerenone exposure and an increased risk of finerenone-related adverse effects Details Telaprevir Ivabradine Corlanor Increased ivabradine exposure, an increased risk of ivabradine-related adverse effects and an increased risk of QT prolongation Details Telaprevir Ketoconazole Topical Extina® Foam Increased ketoconazole exposure, an increased telaprevir exposure and an increased risk for QT interval prolongation Details Telaprevir Lovastatin Altocor® Increased lovastatin exposure and an increased risk of lovastatin-related adverse effects, such as, risk of myopathy or rhabdomyol... Details Telaprevir Lurasidone Latuda Increased lurasidone exposure Details Telaprevir Methylergonovine Methergine An increased risk of acute ergot toxicity Details Telaprevir Midazolam Nasal Spray Nayzilam Increased midazolam concentrations and risk of prolonged sedation or respiratory depression Details Telaprevir Midazolam Injection Nayzilam Increased midazolam concentrations and risk of prolonged sedation or respiratory depression Details Telaprevir Naloxegol Movantik Increased naloxegol exposure and an increased risk of naloxegol-related adverse effects Details Telaprevir Nimodipine Nimotop Increased serum nimodipine concentrations Details

Major

Telaprevir Acetaminophen And Codeine Capital® & Codeine Explained Increased codeine and morphine exposure Details Telaprevir Sertraline Explained An increased risk of QT interval prolongation Details Telaprevir Buprenorphine Belbuca Explained An increased risk of QT interval prolongation, increased buprenorphine exposure and an increased risk of buprenorphine-related adv... Details Telaprevir Relugolix Orgovyx Explained Increased relugolix exposure and an increased risk of QT interval prolongation Details Telaprevir Acalabrutinib Calquence Increased acalabrutinib exposure Details Telaprevir Ado-Trastuzumab Emtansine Injection KADCYLA Increased exposure of cytotoxic component DM1 (maytansine derivative) and risk of toxicity Details Telaprevir Amisulpride Injection Barhemsys Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Telaprevir Apixaban Eliquis Explained Increased apixaban exposure and an increased risk of bleeding Details Telaprevir Arsenic Trioxide Trisenox Increased risk of QT-interval prolongation and torsade de pointes Details Telaprevir Aripiprazole Injection Abilify Increased ARIPiprazole exposure and an increased risk of QT interval prolongation Details Telaprevir Arsenic Trioxide Injection Trisenox Increased risk of QT-interval prolongation and torsade de pointes Details Telaprevir Asciminib Scemblix Increased asciminib exposure and an increased risk of asciminib-related adverse effects Details Telaprevir Asenapine Transdermal Patch Secuado Increased risk of QT interval prolongation Details Telaprevir Atogepant Qulipta Altered atogepant exposure Details Telaprevir Avapritinib Ayvakit Increased avapritinib exposure and increased incidence and severity of adverse reactions Details Telaprevir Azithromycin AzaSite An increased risk of QT interval prolongation and torsade de pointes Details Telaprevir Betrixaban Bevyxxa® Increased betrixaban exposure and increased risk of bleeding Details Telaprevir Atorvastatin Atorvaliq Increased atorvastatin concentrations Details Telaprevir Cariprazine Vraylar Explained Increased exposure to cariprazine and its active metabolite, didesmethylcariprazine Details Telaprevir Afatinib Gilotrif Increased exposure of afatinib Details Telaprevir Amlodipine Amvaz® Increased amLODIPine exposure, an increased risk of hypotension and edema and reduced amLODIPine exposure Details Telaprevir Anagrelide Agrylin Increased risk of QT interval prolongation Details Telaprevir Avanafil Stendra Decreased avanafil clearance and increased avanafil plasma concentration Details Telaprevir Axitinib Inlyta Increased axitinib plasma concentrations Details Telaprevir Beclomethasone Nasal Spray Beconase Increased beclomethasone exposure and an increased risk of beclomethasone-related adverse reactions Details